Correlation Between TSS, Common and Integrated Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TSS, Common and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TSS, Common and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TSS, Common Stock and Integrated Biopharma, you can compare the effects of market volatilities on TSS, Common and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TSS, Common with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of TSS, Common and Integrated Biopharma.

Diversification Opportunities for TSS, Common and Integrated Biopharma

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between TSS, and Integrated is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding TSS, Common Stock and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and TSS, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TSS, Common Stock are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of TSS, Common i.e., TSS, Common and Integrated Biopharma go up and down completely randomly.

Pair Corralation between TSS, Common and Integrated Biopharma

If you would invest  504.00  in TSS, Common Stock on August 31, 2024 and sell it today you would earn a total of  466.00  from holding TSS, Common Stock or generate 92.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy1.59%
ValuesDaily Returns

TSS, Common Stock  vs.  Integrated Biopharma

 Performance 
       Timeline  
TSS, Common Stock 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TSS, Common Stock are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain basic indicators, TSS, Common demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Integrated Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

TSS, Common and Integrated Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TSS, Common and Integrated Biopharma

The main advantage of trading using opposite TSS, Common and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TSS, Common position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.
The idea behind TSS, Common Stock and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine